PuraCath Medical
PrivateLast Round
Grant
Jul 6, 2023
Total Funding Raised
$11.72M
Company Overview
PuraCath Medical operates in Healthcare & Life Sciences and is based in Newark, California. Its latest recorded funding round was a Grant round in July 2023.
PuraCath Medical is a medical technology company that develops devices to reduce the risk of infections associated with catheter use.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PuraCath Medical Comparables
Compare PuraCath Medical with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| UV Clinical | 85% | |
| Light Line Medical | 84% | |
| Relavo | 82% |
For institutional investors. Book with your work email.
PuraCath Medical Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 6, 2023 | ||||
| Grant | Apr 21, 2022 | ||||
| Grant | Feb 1, 2020 | ||||
| Grant | Jul 1, 2017 | ||||
| Grant | Sep 30, 2016 | ||||
Series A | Jan 26, 2016 |
For institutional investors. Book with your work email.
PuraCath Medical Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rising Tide Fund | Series A |
| Cota Capital | Series A |
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| Signatures Capital | Series A |
| U.S. Army Medical Research Acquisition Activity | Grant |
| National Science Foundation | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 30, 2016
$150K grant from U.S. Army Medical Research Acquisition Activity.
- Jan 26, 2016
$1.8M round led by Cota Capital.
For institutional investors. Book with your work email.
PuraCath Medical Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about PuraCath Medical's valuation, stock price, and market status.
Is PuraCath Medical a public or private company?
PuraCath Medical is a private company.
What is the current stock price of PuraCath Medical?
PuraCath Medical is a private company, so its shares have no public market price. Caplight tracks PuraCath Medical's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is PuraCath Medical worth (valuation)?
Valuation information for PuraCath Medical is not publicly available.
Can I buy PuraCath Medical stock?
PuraCath Medical shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was PuraCath Medical's last funding round?
PuraCath Medical's most recent funding round was Grant on July 6, 2023.
Who are the main investors in PuraCath Medical?
Key investors in PuraCath Medical include NIH RADx, National Science Foundation.
Will PuraCath Medical IPO soon?
No public IPO plans have been announced for PuraCath Medical.
How can I track PuraCath Medical secondary market activity?
Caplight tracks bids, offers, and trades in PuraCath Medical's shares on secondary markets.